SYNCOM FORMULATIONS (INDIA) . Q3 FY25 Results
SYNCOM FORMULATIONS (INDIA) . has released its financial results for the Q3 quarter of Financial Year 24-2025. Here's a comprehensive breakdown of the company's performance:
Revenue Analysis
- Current Quarter Revenue: Rs. 127.53 Cr
- Quarter-on-Quarter (QoQ) Change: 24.65% (Previous Quarter: Rs. 102.31 Cr )
- Year-on-Year (YoY) Change: 95.78% (Same Quarter Last Year: Rs. 65.14 Cr )
Profitability Metrics
- Net Profit: Rs. 13.00 Cr
- QoQ Profit Change: 17.05% (Previous Quarter: Rs. 11.11 Cr )
- YoY Profit Change: 85.70% (Same Quarter Last Year: Rs. 7.00 Cr )
Shareholder Returns
- Earnings Per Share (EPS): Rs. 0.14
- QoQ EPS Change: -12.50% (Previous Quarter: Rs. 0.16)
- YoY EPS Change: 55.56% (Same Quarter Last Year: Rs. 0.09)
Performance Summary
Exceptional
SYNCOM FORMULATIONS (INDIA) . had a fantastic increase in sales, which led to big profit jumps. This shows there's high demand for their products or services.
This analysis provides a snapshot of SYNCOM FORMULATIONS (INDIA) .'s financial performance. Investors and analysts should consider these results in the context of broader market trends and the company's long-term strategy.
Disclaimer:
This information is for informational purposes only. Please reverify all details from official sources before making any financial decisions. The accuracy and completeness of this data cannot be guaranteed.